Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment.

Journal of neurovirology - 1 Oct 2013

Morales Diana, Hechavarria Rosa, Wojna Valerie, Acevedo Summer F

Abstract excerpt

YWHAE (14-3-3ε) protein levels are considered to be a reliable biomarker for neurodegeneration. The YWHAE protein interacts both directly and indirectly with human immunodeficiency virus (HIV) accessory proteins, leading to cell death. The purpose of this study was to examine the relationship between YWHAE polymorphisms and HIV-associated neurocognitive disorder (HAND) and the relationship between YWHAE protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 14-3-3 Proteins
Share to Cognition Disorders
Share to Hispanic or Latino

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HIV Seronegativity

Share to HIV Seropositivity

Share to Longitudinal Studies

Share to Neuropsychological Tests

Source

Open in PubMed Open full text

Identifiers

PMID: 23982958
DOI: 10.1007/s13365-013-0200-z
PMCID: PMC3962987

Genes

YWHAE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

YWHAE/14-3-3ε: a potential novel genetic risk factor and CSF biomarker for HIV neurocognitive impairment.PMID 23982958Read ↗

The Genetic Fingerprint of HIV in the Brain: Insights into Neurocognitive DysfunctionSemantic proximity Read ↗

Genomic Factors and Therapeutic Approaches in HIV-Associated Neurocognitive Disorders: A Comprehensive ReviewSemantic proximity Read ↗

Genome-wide association study of HIV-associated neurocognitive disorder (HAND): A CHARTER group study.Semantic proximity Read ↗

APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.Semantic proximity Read ↗

Host genetic factors predisposing to HIV-associated neurocognitive disorder.Semantic proximity Read ↗

Unbiased serology reveals autoimmunity and HIV antibody signatures in HIV CNS EscapeSemantic proximity Read ↗

An exploratory pilot study on the involvement of APOE, HFE, C9ORF72 variants and comorbidities in neurocognitive and physical performance in a group of HIV-infected people.Semantic proximity Read ↗

Cerebrospinal Fluid Proteomic Profiling of HIV-1-Infected Patients with Cognitive ImpairmentSemantic proximity Read ↗

Complement and HIV-I infection/HIV-associated neurocognitive disordersSemantic proximity Read ↗

Presence of Epstein–Barr virus DNA in cerebrospinal fluid is associated with greater HIV RNA and inflammationSemantic proximity Read ↗

Genetic Variations in EIF2AK3 are Associated with Neurocognitive Impairment in People Living with HIV.Semantic proximity Read ↗

CSF proteomic fingerprints for HIV-associated cognitive impairmentSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.